CYNTHIA AKIN: Open Payments
NPI 1093312324 · PALM BAY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$926 in 25 payments from 10 companies in 2025. Trend: 2023 $17 · 2024 $276 · 2025 $926
Food & beverage: $926
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $425 |
| ABBVIE INC. | 6 | $192 |
| AstraZeneca Pharmaceuticals LP | 3 | $153 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Exact Sciences Corporation | 1 | $27 |
| Corcept Therapeutics | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| CVRx, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $17 |
Products named: Ozempic, QULIPTA, AIRSUPRA, Wegovy, UBRELVY, LEQVIO, BREZTRI, Cologuard Collection Kit.
Industry payments across FL — which companies pay providers there.
